Le Lézard
Classified in: Oil industry, Environment, Science and technology, Covid-19 virus
Subjects: PDT, PLW

Ellomay Capital Reports Receipt of Operation Permit by the Talasol Project


TEL AVIV, Israel, Sept. 24, 2020 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported that the photovoltaic plant constructed by Talasol Solar S.L., with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain (the "Talasol Project"), received the final start-up certificate ("Acta de puesta en servicio definitiva"), in accordance with Article 132 of Royal Decree 1955/2000 from the Administration. The start-up certificate is the last authorization required by the Administration from a permitting perspective for operation of the Talasol Project. Also, it enables Talasol to request the release of the grid bond, which Talasol expects to do in the coming days.

The Company owns 51% of Talasol Solar S.L.

Ran Fridrich, CEO and a board member of the Company, commented: "As of today, Talasol's construction is on the verge of completion and the operating permit has been obtained. This permit is the final permit issued by the government, and once obtained the guarantees provided upon receipt of the building permit will be released. The process of connection to the grid, which is expected to take between 5-7 weeks, is expected to commence shortly."

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

Ellomay Capital is controlled by Mr. Shlomo Nehama, Mr. Hemi Raphael and Mr. Ran Fridrich. Mr. Nehama is one of Israel's prominent businessmen and the former Chairman of Israel's leading bank, Bank Hapohalim, and Messrs. Raphael and Fridrich both have vast experience in financial and industrial businesses. These controlling shareholders, along with Ellomay's dedicated professional management, accumulated extensive experience in recognizing suitable business opportunities worldwide. Ellomay believes the expertise of Ellomay's controlling shareholders and management enables the Company to access the capital markets, as well as assemble global institutional investors and other potential partners. As a result, we believe Ellomay is capable of considering significant and complex transactions, beyond its immediate financial resources.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements.  The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of the Covid-19 pandemic on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company's business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kalia Weintraub
CFO
Tel: +972 (3) 797-1111
Email: [email protected]

SOURCE Ellomay Capital Ltd


These press releases may also interest you

at 16:45
As the final Intergovernmental Negotiating Body (INB) meeting of the World Health Organization (WHO) Pandemic Agreement approaches, the AIDS Healthcare Foundation and the AHF Global Public Health Institute are voicing significant concerns about the...

at 16:30
First Trust Energy Income and Growth Fund (the "Fund") has declared its final common share distribution rate in the amount of $0.30 per share, which as previously announced on April 19, 2024, will be payable on May 2, 2024, to shareholders of record...

at 16:30
First Trust Energy Infrastructure Fund (the "Fund") has declared its final common share distribution rate in the amount of $0.15 per share, which as previously announced on April 19, 2024, will be payable on May 2, 2024, to shareholders of record as...

at 16:30
Surge Copper Corp. ("Surge" or the "Company") announces that it has closed its previously announced non-brokered private placement (the "Side-Car Private Placement") (see April 10, 2024 press release), consisting of 10,000,000 common shares of...

at 16:30
Deverra Therapeutics, Inc., a clinical-stage biotechnology company developing allogeneic universal donor cell therapy treatments to fight cancer and other life-threatening diseases, today announced that the U.S. Food and Drug Administration (FDA)...

at 16:25
Aecon Group Inc. ("Aecon" or the "Company") today reported results for the first quarter of 2024. "With backlog of $6.3 billion, a strong bid pipeline, and recurring revenue programs continuing to see robust demand, Aecon is focused on achieving...



News published on and distributed by: